As of 2025-05-14, the Intrinsic Value of EuBiologics Co Ltd (206650.KQ) is 9,293.31 KRW. This 206650.KQ valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 13,410.00 KRW, the upside of EuBiologics Co Ltd is -30.70%.
The range of the Intrinsic Value is 7,131.68 - 13,750.24 KRW
Based on its market price of 13,410.00 KRW and our intrinsic valuation, EuBiologics Co Ltd (206650.KQ) is overvalued by 30.70%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 7,131.68 - 13,750.24 | 9,293.31 | -30.7% |
| DCF (Growth 10y) | 19,530.40 - 39,356.55 | 26,018.00 | 94.0% |
| DCF (EBITDA 5y) | 26,458.09 - 45,034.09 | 32,434.29 | 141.9% |
| DCF (EBITDA 10y) | 41,701.06 - 74,230.51 | 52,381.06 | 290.6% |
| Fair Value | 2,610.17 - 2,610.17 | 2,610.17 | -80.54% |
| P/E | 12,121.64 - 19,288.99 | 14,481.66 | 8.0% |
| EV/EBITDA | 14,345.26 - 23,998.74 | 20,124.87 | 50.1% |
| EPV | 338.94 - 357.42 | 348.18 | -97.4% |
| DDM - Stable | 4,951.68 - 13,097.23 | 9,024.47 | -32.7% |
| DDM - Multi | 10,977.54 - 22,724.55 | 14,821.90 | 10.5% |
| Market Cap (mil) | 491,074.20 |
| Beta | 0.16 |
| Outstanding shares (mil) | 36.62 |
| Enterprise Value (mil) | 481,170.47 |
| Market risk premium | 5.82% |
| Cost of Equity | 7.48% |
| Cost of Debt | 4.25% |
| WACC | 7.40% |